Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic

Michal Herman-Edelstein1, Merlin C Thomas, Vicki Thallas-Bonke

  • 1JDRF Danielle Alberti Memorial Centre for Diabetes Complications,Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria,Australia.

Diabetes
|April 28, 2011
PubMed
Abstract

Insights

Diabetic nephropathy causes podocyte dedifferentiation, altering their specialized function. These changes, including proliferation and apoptosis, contribute to kidney disease progression.

Area of Science:

  • Nephrology
  • Cell Biology
  • Diabetic Complications

Background:

  • Diabetic nephropathy involves podocyte dedifferentiation, a loss of specialized features.
  • This dedifferentiation is linked to profibrotic, proinflammatory, and proliferative changes.

Purpose of the Study:

  • To investigate the mechanisms of podocyte dedifferentiation in diabetic nephropathy.
  • To examine the role of transforming growth factor-beta 1 (TGF-β1) and angiotensin II in this process.

Main Methods:

  • Experiments utilized human podocytes treated with TGF-β1 or angiotensin II.
  • Inhibitor SB-431542 was used to block the TGF-β type I receptor kinase.
  • Gene and protein expression were analyzed via real-time RT-PCR and immunofluorescence, correlated with in vivo diabetic models.

Main Results:

  • TGF-β1 induced podocyte dedifferentiation, characterized by foot process effacement and altered tight junctions.
  • A decrease in glomerular epithelial markers and an increase in mesenchymal markers were observed.
  • Increased cellular proliferation and apoptosis were noted, mirroring changes seen in experimental diabetes.

Conclusions:

  • Mature podocytes dedifferentiate in response to TGF-β, adopting a more embryonic phenotype.
  • This dedifferentiation contributes to increased proliferation, apoptosis, and ultimately, kidney damage in diabetic nephropathy.
  • These pathoadaptive changes are early indicators of diabetic kidney disease, leading to albuminuria and glomerulosclerosis.